Two Sigma Securities, LLC Compugen LTD Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.53 - $2.0 $11,734 - $44,282	22,141 New	22,141 $43,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.38 $1,662 - $4,024	2,916 Added 13.08%	25,213 $28,000
Q1 2023 May 15, 2023	BUY	$0.68 - $1.11 $15,161 - $24,749	22,297 New	22,297 $15,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $23,925 - $84,102	36,251 New	36,251 $24,000
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $48,399 - $81,367	-17,536 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $71,722 - $125,557	17,536 New	17,536 $75,000
Q1 2018 May 15, 2018	SELL	$2.5 - $4.45 $77,010 - $137,077	-30,804 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.35 - $4.0 $72,389 - $123,216	30,804	30,804 $77,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.